Candidiasis, Invasive: Clinical Trials

2 trials for Candidiasis, Invasive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Candidiasis, Invasive: new trials by email Literature Review of Candidiasis, Invasive trials Research Report on Candidiasis, Invasive

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin
1,3-β-D-glucan quantification, Micafungin - Invasive Candidiasis
Phase 4TerminatedFadoi Foundation, Italy142018-07-182021-04-12
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
Micafungin - Candidemia, Candidiasis
Phase 4TerminatedAstellas Pharma China, Inc.592013-09-262024-11-20

Narrower conditions

Candidemia (1)  ·  Candidiasis (1)

Broader conditions

Bacterial Infections and Mycoses (2)  ·  Infections (2)  ·  Invasive Fungal Infections (2)  ·  Mycoses (2)  ·  Candidiasis (1)  ·  Fungemia (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sepsis (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Micafungin (2)

Sponsors

Astellas Pharma China, Inc. (1)  ·  Fadoi Foundation, Italy (1)

Countries

China (1)  ·  Italy (1)